Lovastatin is a HMG-CoA Reductase Inhibitor for Hypercholesterolemia Research
HMG-CoA, also known as 3-hydroxy-3-methylglutaryl-CoA, is an intermediate in the mevalonate and ketogenic pathways. HMG-CoA reductase catalyzes the conversion of HMG-CoA to mevalonate, an essential step in cholesterol biosynthesis. High…